abeonatherapeutics.com (ABEO) Bozor qiymatining balans qiymatiga nisbati

abeonatherapeutics.com - ABEO emitenti grafik logotipi

Abeona Therapeutics (ABEO) yuqori narxli Pz-cel dori vositasini ishga tushirish orqali epidermoliz bulloza terapiyasi nishasida ustunlikka intilmoqda. Texnologik stek avtomatlashtirilgan bioreaktorlarga asoslangan, ammo dori vositasining yakuniy tekshiruvi shifokorlarning ishtirokini talab qiladi va ko'rsatkich 2.03 darajasida turibdi. Ushbu narx harakati grafigi aktivning bozor kotirovkalarini namoyish etadi. Hujayra mahsulotlarini chiqarish uchun global tozalik standartlariga rioya qilish maqsadida ishlab chiqarish quvvatlari muntazam ravishda yangilanib boriladi.

abeonatherapeutics.com (ABEO) Sof aktivlarga nisbatan bozor kapitallashuvi: 04.07.2022 - 29.10.2026 davri uchun
Abeona Therapeutics yetakchi tovari

R&D yadrosining barqarorligi va noyob kasalliklar bo'yicha ekspertlarning saqlanib qolishi Abeona Therapeutics (ABEO) uchun baholash asosini yaratadi, bu esa bozor qiymatining buxgalteriya qiymatiga nisbati premiumida aks etgan. Ushbu ko'rsatkich joriy bozor narxini sof aktivlar bilan solishtiradi, bu esa investorlarga biznesning haddan tashqari yuqori baholanganlik darajasini baholash va modeldagi yashirin zaifliklardan dalolat berishi mumkin bo'lgan manipulyativ sakrashlarni aniqlash imkonini beradi.

Raqobatchilar tahlili

Vertex Pharmaceuticals (VRTX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti alnylam.com (ALNY)|Bozor qiymatining balans qiymatiga nisbati Insmed|United Therapeutics Corp (UTHR) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BioMarin Pharma (BMRN)|BBIO: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati BGM (BGM Group)|cogentbio.com (COGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Xeris Biopharma Holdings - Bozor kapitallashuvining balans qiymatiga nisbati|Keros Therapeutics Inc (KROS) - Kapitallashuvning sof aktivlarga nisbati|ARCT: Bozor kapitallashuvining balans qiymatiga nisbati|ETON - Balans qiymatiga nisbatan bozor kapitallashuvi|KMDA (Kamada Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati fulcrumtx.com|Bozor qiymatining balans qiymatiga nisbati Mereo BioPharma (MREO)|Bozor qiymatining balans qiymatiga nisbati PLX (Protalix BioTherapeutics Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati PLRX (Pliant Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Applied Therapeutics Inc. (APLT)|RNTX: Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi GELS|AYTU: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Chemomab Therapeutics Ltd. (CMMB)|SRXH (SRx Health Solutions Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PLRZ (Polyrizon Ltd.)|Kapitallashuvning sof aktivlarga nisbati AEZS (Aeterna Zentaris)|CYTH (cyclotherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Inozyme Pharma INZY|RPHM (Reneo Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi|Aeterna Zentaris - Bozor kapitallashuvining balans qiymatiga nisbati